by The global Infertility Devices Market is estimated to be valued at US$ 10,129.9 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Infertility devices are widely used in fertility treatments such as in vitro fertilization (IVF). These devices assist in sperm collection, fertilization, embryo transfer, and storage. Various infertility devices range from embryo storage tanks to micro-manipulators and imaging systems which help track development of embryos and aid in selection of best embryos for implantation.
Market key trends:
One of the key trends in the infertility devices market is the high adoption rate of in vitro fertilization (IVF). IVF is considered as the most effective fertility treatment for infertility issues and its success rate has increased in the past few years due to advancement in infertility devices. As per findings, around 8 million babies have been born worldwide through IVF technology since the first IVF birth in 1978. Rising cases of infertility, increasing delay in childbearing, and high success rate of IVF are fueling growth of this segment. Furthermore, embryo vitrification or cryopreservation method in IVF helps physicians transfer more than one embryo to maximize chances of pregnancy without increasing risk of multiple births. This trend is positively impacting the adoption of infertility devices market.
Segment Analysis
The global infertility devices market is segmented into products, procedure, end-user, and region. Based on product, the market is bifurcated into fertility monitors and Others. Among these, fertility monitors hold the largest market share owing to increasing use of fertility monitors to track monthly cycles and ovulating days. This helps in conceiving naturally and planning fertility treatments.
Key Takeaways
Global Infertility Devices Market Demand is expected to witness high growth, exhibiting CAGR of 8.7% over the forecast period, due to increasing prevalence of infertility disorders due to changing lifestyle and dietary habits.
Regional analysis
North America dominates the global infertility devices market and is expected to maintain its dominance over the forecast period owing to increasing adoption of advanced infertility treatment methods and growing awareness about infertility treatment options in the region. Asia Pacific is expected to witness the highest growth rate during the forecast period due to rising healthcare expenditure, increasing medical tourism, and growing fertility tourism in the region.
Key players
Key players operating in the infertility devices market are Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD, Merck.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
